Bulto Carulla Victor has filed a Form 144 to sell 6,000 American Depositary Shares of Novartis AG, valued at approximately $933,180. This filing, dated October 28, 2026, is significant as it reflects the ongoing activities of company executives in the stock market, particularly in the pharmaceutical sector.

Background

Bulto Carulla Victor is associated with Novartis AG, a prominent player in the pharmaceutical industry, as indicated by the filing. The company is known for its pharmaceutical preparations. The recent filing is part of a series of disclosures, with the most recent prior filing on April 30, 2026, also a Form 144.

What the Filing Says

The filing states that Bulto Carulla Victor intends to sell 6,000 shares of American Depositary Shares of Novartis AG. The approximate market value of the shares is noted to be $933,180. The sale is set to occur on or about October 28, 2026.

Impact

This filing may affect stakeholders within Novartis AG, including investors and other executives. Additionally, it highlights the ongoing trends in executive stock sales, which can influence market perceptions and investor confidence in the pharmaceutical sector.

What's Next

The filing does not say what happens next.

Details of Securities Sold

The Form 144 filing specifies that the shares being sold are American Depositary Shares of Novartis AG, which are traded on the New York Stock Exchange (NYSE). Bulto Carulla Victor acquired these shares through a series of restricted stock vesting transactions, with the most recent acquisition occurring on January 29, 2026, when 4,766 shares were acquired as compensation.

Acquisition History

In total, Bulto Carulla Victor has acquired shares through restricted stock vesting on multiple occasions, including 61 shares on January 20, 2024, 326 shares on January 25, 2024, 638 shares on January 25, 2025, and 209 shares on January 26, 2025. This history indicates a consistent pattern of receiving shares as part of compensation, which aligns with typical executive compensation structures in publicly traded companies.

Broker Information

The sale of the shares will be facilitated by Fidelity Brokerage Services LLC, located in Smithfield, Rhode Island. This brokerage is responsible for executing the transaction on behalf of Bulto Carulla Victor.

Outstanding Shares

As of the filing date, there are approximately 1,908,151,679 units of American Depositary Shares outstanding for Novartis AG. This context is important for understanding the relative size of the sale in relation to the total shares available in the market.

Filing Context

Notably, the filing indicates that there were no securities sold by Bulto Carulla Victor in the past three months, suggesting that this sale may be a significant liquidity event for the executive.